Ubs Group Ag Athenex, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.12 - $0.21 $9,280 - $16,240
77,334 Added 5.17%
1,574,098 $236,000
Q3 2022

Nov 10, 2022
BUY
$0.24 - $1.11 $227,783 - $1.05 Million
949,096 Added 173.3%
1,496,764 $403,000
Q2 2022

Aug 10, 2022
SELL
$0.41 - $0.91 $1,698 - $3,769
-4,142 Reduced 0.75%
547,668 $224,000
Q1 2022

May 16, 2022
BUY
$0.79 - $1.59 $18,027 - $36,282
22,819 Added 4.31%
551,810 $458,000
Q4 2021

Feb 14, 2022
SELL
$1.36 - $2.94 $52,787 - $114,113
-38,814 Reduced 6.84%
528,991 $720,000
Q3 2021

Nov 15, 2021
SELL
$2.97 - $4.84 $233,070 - $379,819
-78,475 Reduced 12.14%
567,805 $1.71 Million
Q2 2021

Aug 13, 2021
SELL
$3.71 - $5.13 $291,583 - $403,187
-78,594 Reduced 10.84%
646,280 $2.99 Million
Q1 2021

May 12, 2021
BUY
$4.08 - $14.75 $2.71 Million - $9.79 Million
663,814 Added 1087.15%
724,874 $3.12 Million
Q4 2020

Feb 11, 2021
BUY
$11.06 - $14.01 $89,751 - $113,691
8,115 Added 15.33%
61,060 $675,000
Q3 2020

Nov 12, 2020
SELL
$10.26 - $14.55 $95,223 - $135,038
-9,281 Reduced 14.91%
52,945 $641,000
Q2 2020

Jul 31, 2020
SELL
$7.11 - $13.76 $155,111 - $300,188
-21,816 Reduced 25.96%
62,226 $857,000
Q1 2020

May 01, 2020
SELL
$5.71 - $15.85 $222,061 - $616,406
-38,890 Reduced 31.64%
84,042 $650,000
Q4 2019

Feb 14, 2020
SELL
$9.6 - $17.75 $880,080 - $1.63 Million
-91,675 Reduced 42.72%
122,932 $1.88 Million
Q3 2019

Nov 14, 2019
BUY
$12.16 - $21.0 $1.83 Million - $3.15 Million
150,205 Added 233.23%
214,607 $2.61 Million
Q2 2019

Aug 14, 2019
BUY
$9.44 - $19.8 $146,197 - $306,642
15,487 Added 31.66%
64,402 $1.28 Million
Q1 2019

May 14, 2019
SELL
$11.11 - $13.49 $808,296 - $981,451
-72,754 Reduced 59.8%
48,915 $599,000
Q4 2018

Feb 14, 2019
BUY
$10.24 - $15.49 $716,144 - $1.08 Million
69,936 Added 135.19%
121,669 $1.54 Million
Q3 2018

Nov 14, 2018
BUY
$15.53 - $19.97 $423,161 - $544,142
27,248 Added 111.28%
51,733 $804,000
Q2 2018

Aug 14, 2018
SELL
$15.88 - $19.5 $256,160 - $314,554
-16,131 Reduced 39.72%
24,485 $457,000
Q1 2018

May 15, 2018
SELL
$13.53 - $17.47 $116,344 - $150,224
-8,599 Reduced 17.47%
40,616 $691,000
Q4 2017

Feb 14, 2018
BUY
$14.41 - $19.15 $681,621 - $905,833
47,302 Added 2472.66%
49,215 $782,000
Q3 2017

Nov 14, 2017
BUY
$13.5 - $19.51 $11,677 - $16,876
865 Added 82.54%
1,913 $34,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,048
1,048 $17,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email